How Clinically Efficient Is Lumacaftor/Ivacaftor for Cystic Fibrosis Patients? An Updated Literature Review.

Perveen, Sumera; Chaudhry, Muhammad Reza; AlBabtain, Sarah; Amreen, Sana; Brar, Simrandeep K; Zeb, Mehwish; Khan, Safeera

Perveen, Sumera; Chaudhry, Muhammad Reza; AlBabtain, Sarah; Amreen, Sana; Brar, Simrandeep K; Zeb, Mehwish; Khan, Safeera.

Afiliação

Perveen S; Internal Medicine/Family Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Chaudhry MR; Family Medicine, Ibne Sina Hospital Parco Mid-Country Refinery, Muzaffargarh, PAK.
AlBabtain S; Psychiatry, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Amreen S; Public Health and Preventive Medicine, St. George's University School of Medicine, St. George's, GRD.
Brar SK; Psychiatry and Behavioral Sciences, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Zeb M; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Khan S; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Cureus ; 12(12): e12251, 2020 Dec 24.

Article em En | MEDLINE | ID: mdl-33520477

Palavras-chave

cystic fibrosis; cystic fibrosis/drug therapy; cystic fibrosis/therapy; ivacaftor; ivacaftor/lumacaftor combination; lumacaftor; orkambi

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Aspecto: Patient_preference Idioma: En Revista: Cureus Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google